EXoZymes Touts 10x Output Gain Against a Tight Cash Runway

EXoZymes' Q2 2026 call paired a claimed 10x productivity leap and $20 million of non-dilutive grants with an acknowledged tight cash runway ahead of a mid-2027 market entry.